←
Rik Lories776 posts
Rik Lories avatar

Rik Lories

@TissueHomandDis

Head Division of Rheumatology UZ Leuven, Head Department of Development & Regeneration and Director Skeletal Biology & Engineering Research Center KU Leuven

◷ Joined January 2013▧ 79 Photos and videos
Ioannis Papantoniou avatar
⟳ Rik Lories retweeted
Ioannis Papantoniou@i_papantoniou·25 Feb 2025

Our recent Advanced Science paper, explores the development of #magnetically augmented cartilaginous #organoids.This 4D 🧲#biofabrication approach leads to a multifaceted influence on #bioassembly, ECM organisation, 🦿gene pathways and in vivo outcome🦴! advanced.onlinelibrary.wiley…

Daniel Langer avatar
⟳ Rik Lories retweeted
Daniel Langer@DLanger6·4 Dec 2024

Respiratory muscle dysfunction can be both a cause and consequence of respiratory failure. It is often reversible and should be diagnosed and treated. This review covers available assessment and treatment options in acute and chronic respiratory failure. bit.ly/3XZBeVa

Heidi Declercq avatar
⟳ Rik Lories retweeted
Heidi Declercq@TissueEngKulak·3 Dec 2024

Always dreamed of a work-out of (your) muscles in a lab? This is your chance! We have a PhD vacancy on '4D bioprinting of vascularized, myogenic tissue based on hybrid nanocomposites'. Join our Tissue Engineering Lab at KU Leuven Campus Kortrijk! kuleuven.be/personeel/jobsit…

Frank Zaucke avatar
⟳ Rik Lories retweeted
Frank Zaucke@FZaucke·28 Oct 2024

I am more than excited that our manuscript (written by @ZsJeneiLanzl and myself) has been accepted for publication👇👇👇👇👇👇 Osteoarthritis year in review 2024: biology - Osteoarthritis and Cartilage oarsijournal.com/article/S10…

Silvia Monteagudo avatar
⟳ Rik Lories retweeted
Silvia Monteagudo@SilviaMonteag·26 Oct 2024

Unlocking a Detrimental Role of IGF1 in Osteoarthritis: A New Target for Therapeutic Intervention? | Research Communities by Springer Nature communities.springernature.c…

Rik Lories avatar
Rik Lories@TissueHomandDis·24 Oct 2024

We hope this research brings us one step closer to finding a disease-modifying therapy for osteoarthritis. Stay tuned as we explore new ways to target the Wnt-IGF1 axis in future therapeutic approaches. 13/14

Post attachment
Rik Lories avatar
Rik Lories@TissueHomandDis·24 Oct 2024

Finally, decreasing IGF1 in articular chondrocytes from OA patients favors the restoration of a healthy molecular profile. By reducing IGF1, we can protect the joint from Wnt-driven damage while preserving cartilage integrity! 12/14

Post attachment
Rik Lories avatar
Rik Lories@TissueHomandDis·24 Oct 2024

We then investigated the translational implications of the identified Wnt/IGF1 link using a clinically relevant mouse model of posttraumatic OA. Again, Igf1 deficient mice were protected against OA. 11/14

Post attachment
Rik Lories avatar
Rik Lories@TissueHomandDis·24 Oct 2024

We also found TCF/LEF binding sites in the IGF1 gene promoter, highly conserved across species, indicating that IGF1 is a direct Wnt target gene! This provides a clear molecular mechanism for how Wnt signaling leads to increased IGF1 in the joint, driving OA. 10/14

Post attachment